openPR Logo
Press release

Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda, Neurogastrx, Inc, PTC Thera

01-16-2025 03:54 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Gastroparesis Pipeline Trends 2024: Clinical Trials,

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Gastroparesis pipeline constitutes 10+ key companies continuously working towards developing 11+ Gastroparesis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Gastroparesis Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/gastroparesis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Gastroparesis Market.

The Gastroparesis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Gastroparesis Pipeline Report:

*
Companies across the globe are diligently working toward developing novel Gastroparesis treatment therapies with a considerable amount of success over the years.

*
Gastroparesis companies working in the treatment market are CinDome Pharma, Inc., Evoke Pharma, Vanda Pharmaceuticals, Ironwood Pharmaceuticals, Takeda, Neurogastrx, Inc, PTC Therapeutics, Theravance Biopharma, Chugai Pharma, GlaxoSmithKline, Processa Pharmaceuticals, and others, are developing therapies for the Gastroparesis treatment

*
Emerging Gastroparesis therapies in the different phases of clinical trials are- CIN-102, Metoclopramide Nasal Spray, Tradipitant, IW-9179, TAK-954, NG101, CNSA-001, velusetrag, GM-611, Camicinal, PCS12852, and others are expected to have a significant impact on the Gastroparesis market in the coming years.

*
In September 2024, The US Food and Drug Administration (FDA) has rejected the new drug application (NDA) submitted by Vanda Pharmaceuticals for the use of tradipitant in treating gastroparesis symptoms.

Gastroparesis Overview

Gastroparesis is a condition that affects the stomach's ability to empty its contents due to nerve damage caused by diabetes. The condition occurs when high blood sugar levels over time damage the vagus nerve, which controls the muscles of the stomach. This results in delayed gastric emptying, causing symptoms like nausea, vomiting, bloating, abdominal pain, and feeling full quickly after eating. It can lead to poor blood sugar control and malnutrition. Treatment focuses on managing blood sugar levels, dietary changes, and medications to improve stomach motility and relieve symptoms.

Get a Free Sample PDF Report to know more about Gastroparesis Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/gastroparesis-pipeline-insight [https://www.delveinsight.com/report-store/gastroparesis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Emerging Gastroparesis Drugs Under Different Phases of Clinical Development Include:

*
CIN-102: CinDome Pharma, Inc.

*
Metoclopramide Nasal Spray: Evoke Pharma

*
Tradipitant: Vanda Pharmaceuticals

*
IW-9179: Ironwood Pharmaceuticals

*
TAK-954: Takeda

*
NG101: Neurogastrx, Inc

*
CNSA-001: PTC Therapeutics

*
velusetrag: Theravance Biopharma

*
GM-611: Chugai Pharma

*
Camicinal: GlaxoSmithKline

*
PCS12852: Processa Pharmaceuticals

Gastroparesis Route of Administration

Gastroparesis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

*
Oral

*
Parenteral

*
Intravenous

*
Subcutaneous

*
Topical

Gastroparesis Molecule Type

Gastroparesis Products have been categorized under various Molecule types, such as

*
Monoclonal Antibody

*
Peptides

*
Polymer

*
Small molecule

*
Gene therapy

Gastroparesis Pipeline Therapeutics Assessment

*
Gastroparesis Assessment by Product Type

*
Gastroparesis By Stage and Product Type

*
Gastroparesis Assessment by Route of Administration

*
Gastroparesis By Stage and Route of Administration

*
Gastroparesis Assessment by Molecule Type

*
Gastroparesis by Stage and Molecule Type

DelveInsight's Gastroparesis Report covers around 11+ products under different phases of clinical development like

*
Late-stage products (Phase III)

*
Mid-stage products (Phase II)

*
Early-stage product (Phase I)

*
Pre-clinical and Discovery stage candidates

*
Discontinued & Inactive candidates

*
Route of Administration

Further Gastroparesis product details are provided in the report. Download the Gastroparesis pipeline report to learn more about the emerging Gastroparesis therapies [https://www.delveinsight.com/sample-request/gastroparesis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key companies in the Gastroparesis Therapeutics Market include:

Key companies developing therapies for Gastroparesis are - Bayer AG, Cipla Limited, Evoke Pharma, Pfizer Inc., Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Salix Pharmaceuticals, Inc., The Takeda Pharmaceutical, Teva Pharmaceutical, and others.

Gastroparesis Pipeline Analysis:

The Gastroparesis pipeline report provides insights into

*
The report provides detailed insights about companies that are developing therapies for the treatment of Gastroparesis with aggregate therapies developed by each company for the same.

*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Gastroparesis Treatment.

*
Gastroparesis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

*
Gastroparesis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Gastroparesis market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Gastroparesis drugs and therapies [https://www.delveinsight.com/sample-request/gastroparesis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Gastroparesis Pipeline Market Drivers

*
Growing prevalence of diabetes, Unmet medical need, Advancements in drug development, Improved awareness and diagnosis, Regulatory support for innovation, are some of the important factors that are fueling the Gastroparesis Market.

Gastroparesis Pipeline Market Barriers

*
However, Limited effective treatment options, Challenges in drug development, Adverse side effects, High treatment costs, Regulatory challenges, and other factors are creating obstacles in the Gastroparesis Market growth.

Scope of Gastroparesis Pipeline Drug Insight

*
Coverage: Global

*
Key Gastroparesis Companies: CinDome Pharma, Inc., Evoke Pharma, Vanda Pharmaceuticals, Ironwood Pharmaceuticals, Takeda, Neurogastrx, Inc, PTC Therapeutics, Theravance Biopharma, Chugai Pharma, GlaxoSmithKline, Processa Pharmaceuticals, and others

*
Key Gastroparesis Therapies: CIN-102, Metoclopramide Nasal Spray, Tradipitant, IW-9179, TAK-954, NG101, CNSA-001, velusetrag, GM-611, Camicinal, PCS12852, and others

*
Gastroparesis Therapeutic Assessment: Gastroparesis current marketed and Gastroparesis emerging therapies

*
Gastroparesis Market Dynamics: Gastroparesis market drivers and Gastroparesis market barriers

Request for Sample PDF Report for Gastroparesis Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/gastroparesis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Gastroparesis Report Introduction

2. Gastroparesis Executive Summary

3. Gastroparesis Overview

4. Gastroparesis- Analytical Perspective In-depth Commercial Assessment

5. Gastroparesis Pipeline Therapeutics

6. Gastroparesis Late Stage Products (Phase II/III)

7. Gastroparesis Mid Stage Products (Phase II)

8. Gastroparesis Early Stage Products (Phase I)

9. Gastroparesis Preclinical Stage Products

10. Gastroparesis Therapeutics Assessment

11. Gastroparesis Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Gastroparesis Key Companies

14. Gastroparesis Key Products

15. Gastroparesis Unmet Needs

16 . Gastroparesis Market Drivers and Barriers

17. Gastroparesis Future Perspectives and Conclusion

18. Gastroparesis Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=gastroparesis-pipeline-trends-2024-clinical-trials-therapeutic-innovations-and-fda-approvals-cindome-pharma-inc-evoke-pharma-vanda-pharma-ironwood-pharma-takeda-neurogastrx-inc-ptc-thera]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda, Neurogastrx, Inc, PTC Thera here

News-ID: 3818695 • Views:

More Releases from ABNewswire

Navigating the Digital Landscape: Why IT Support is Crucial for Markham Businesses
Navigating the Digital Landscape: Why IT Support is Crucial for Markham Business …
In today's fast-paced digital world, technology is the backbone of nearly every successful business. For companies in Markham, ensuring your IT infrastructure is robust, secure, and efficient is not just an advantage - it's a necessity. NetFusion Designs Inc. offers Markham IT Support to help businesses thrive in this competitive environment. The Importance of Reliable IT Support Imagine trying to run a race with a pebble in your shoe. That's what it
Barrington Basement Remodeling: Unlock Home's Hidden Potential with NeatFix
Barrington Basement Remodeling: Unlock Home's Hidden Potential with NeatFix
At NeatFix LLC, we specialize in home remodeling services that bring your vision to life, turning dull, unused basements into functional and stylish areas you'll love. When it comes to home remodeling in Barrington, basements are often the most overlooked spaces in a house. Yet, they hold immense potential to transform your home into something extraordinary. Whether you're looking to add more living space, increase your property value, or simply create
Expert Roof Repair Services in Fort Collins: Pro Roofing America Delivers Reliable Solutions for Every Home
Expert Roof Repair Services in Fort Collins: Pro Roofing America Delivers Reliab …
Pro Roofing America - Fort Collins Roofers has built a reputation for delivering top-notch roof repair service that combines expertise, quality materials, and a commitment to customer satisfaction. Whether it's a minor leak or significant storm damage, their team of skilled roofers is equipped to handle any challenge, ensuring homes remain safe and secure. When it comes to maintaining the integrity of a home, few things are as critical as a
Secrets to a Flawless Finish in Cabinet Painting
Secrets to a Flawless Finish in Cabinet Painting
Cabinet painting is the secret to achieving a fresh, modern look without the hefty price tag of a full renovation. Whether you're updating a tired space or adding value to your home, a flawless finish in cabinet painting can completely elevate your interiors. In this post, we'll reveal the key steps to achieving professional-quality results, share tips from top cabinet painting services, and explain why partnering with the right painting

All 5 Releases


More Releases for Gastroparesis

Gastroparesis Drugs Market Analysis by 2020-2025
Scope of the Report: The worldwide market for Gastroparesis Drugsis expected to grow at a CAGR of roughly x% over the next five years, will reach x million US$ in 2024, from x million US$ in 2019, according to a new Global Info Researchstudy. The report presents the market outlook for the Indian Phospho Gypsum product from the year 2019 to the year 2025. The report provides a definition of the product.
Gastroparesis Drugs Market - Use of Gastroparesis Drugs Is Highest In North Amer …
The Gastroparesis Drugs Market is projected to reach $ 6,448.6 billion, an average annual rate of 4.7% from 2017 to 2023. Gastric paralysis affects the normal spontaneous movement of the gastrointestinal muscles and interferes with normal digestion, causing problems related to nausea, vomiting and blood sugar levels and nutrition. Gastroparesis can be caused by diabetes or after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, and anti-vomiting have been developed to
Diabetic Gastroparesis-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the “Diabetic Gastroparesis-Pipeline Review H1 2017” this report provides an overview of the Diabetic Gastroparesis-Pipeline landscape.  Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts
Diabetic Gastroparesis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Diabetic Gastroparesis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H2 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels
Gastroparesis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status
Diabetic Gastroparesis - Pipeline Market Research Report, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Diabetic Gastroparesis - Pipeline Insight, 2017”. This report provides comprehensive insights about pipeline drugs across this Diabetic Gastroparesis. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Diabetic Gastroparesis. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1214082 This report provides information on the therapeutic development for